top of page
Search

Poster #100 - Sathyanarayanan Vaidhyanathan

  • vitod24
  • Oct 20
  • 1 min read

tatDB/tarDB: cancer use cases and machine learning


Sathyanarayanan Vaidhyanathan, Adesupo Adetowubo, Sarthak Chandervanshi, Hameed Sanusi, and Andrey Grigoriev* Department of Biology, Center for Computational and Integrative Biology, Rutgers University, Camden, NJ 08102, USA


Ribosomal RNA-derived fragments (rRFs) and transfer RNA-derived fragments (tRFs) are often neglected as noise while analyzing experimental data like CLASH and CLIP, which capture RNA-RNA interactions loaded into Argonaute protein complexes. The growing field of rRFs is hindered due to a lack of resources to understand rRF functions and target groups. Our previous analysis of experimental data from human HEK293 cells capturing crosslinked Argonaute 1-RNA complexes showed tRFs and rRFs, as a class of emerging post-transcriptional regulators of gene expression, likely bind to the transcripts of target genes (Guan, NAR, 2021, Guan, RNA Biol., 2019 ). We identified chimeric guide-target pairs to identify multiple rRF/tRF isoforms, their targets, and their binding patterns. To expand the domain knowledge about the rRFs/tRFs, targets, and interaction sites, we designed a web-based database, tatDB (tRF-target pairs) and tarDB (rRF-target pairs). The goal is to provide a resource for building users' hypotheses on the potential roles of tRFs/ rRFs for experimental validation.

 
 
 

Recent Posts

See All
Poster #9 - Yuheng Du

Cell-Type-Resolved Placental Epigenomics Identifies Clinically Distinct Subtypes of Preeclampsia Yuheng Du, Ph.D. Student, Department of Computational Medicine and Bioinformatics, University of Michig

 
 
 
Poster #15 - Jiayi Xin

Interpretable Multimodal Interaction-aware Mixture-of-Experts Jiayi Xin, BS, PhD Student, University of Pennsylvania, PA, USA Sukwon Yun, MS, PhD Student, University of North Carolina at Chapel Hil

 
 
 
Poster #14 - Aditya Shah

Tumor subtype and clinical factors mediate the impact of tumor PPARɣ expression on outcomes in patients with primary breast cancer. Aditya Shah1,2, Katie Liu1,3, Ryan Liu1, 4, Gautham Ramshankar1, Cur

 
 
 

Comments


bottom of page